NCT03344302View on ClinicalTrials.gov

Oxytocin Administration During Cesarean Section

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

September 30, 2017

Conditions
Postpartum Hemorrhage
Interventions
DRUG

Oxytocin

intravenous infusion of oxytocin 30 units over 5 minutes diluted into 500 mL of normal 0.9% sodium chloride

Trial Locations (1)

Unknown

Assiut Faculty of Medicine, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03344302 - Oxytocin Administration During Cesarean Section | Biotech Hunter | Biotech Hunter